Frailty Assessments for Risk Assessment in Gynecologic Oncology Patients

Recruiting now

Conditions studied: Gynecologic Cancer, Frailty, Oncology

In brief

FARGO is a prospective cohort study that aims to determine the performance of preoperative frailty assessment based on the Frailty Phenotype (FP), compared to a perioperative cardiovascular risk assessment based on the combination of preoperative Revised Cardiac Risk Index (RCRI), age and occurrence of myocardial injury after noncardiac surgery (MINS), in predicting the composite of all-cause death or new disability at 6 months after surgery in patients aged 55 or older. Patients will have confirmed or suspected gynecologic cancer, undergoing cytoreductive or high-risk surgery with or without chemotherapy.

Key facts

Study ID
NCT05738252
Run by
Population Health Research Institute
People needed
280
Starts
2023-06-15
Expected to finish
2025-10-01
Last updated by the study team
2025-04-16

Who can join

Age: 55 and older, up to 110. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.